Gender difference in the relationship between serum uric acid reduction and improvement in body fat distribution after laparoscopic sleeve gastrectomy in Chinese obese patients: a 6-month follow-up

Zhang, Xuane; Zhu, Cuiling; Gao, Jingyang; Mei, Fangyun; Yin, Jiajing; Bu, Le; Cheng, Xiaoyun; Sheng, Chunjun; Qu, Shen

doi:10.1186/s12944-018-0934-y

Lipids in Health and Disease

Table 1 Anthropometric and metabolic characteristics of the patients in normal UA group, high UA group and total patients at baseline and at 6 months after LSG

From: Gender difference in the relationship between serum uric acid reduction and improvement in body fat distribution after laparoscopic sleeve gastrectomy in Chinese obese patients: a 6-month follow-up

Characteristic	NUA (n = 40)		HUA (n = 88)		Total patients (n = 128)
Characteristic	0 month	6 months	0 month	6 months	0 month	6 months
Gender (Make/Female)	13/27	/	35/53	/	48/80	/
Age (years)	35.10 ± 12.77	/	30.93 ± 9.11	/	32.23 ± 10.52	/
BW (kg)	111.63 ± 21.41	81.37 ± 16.24**	113.51 ± 23.68	86.37 ± 19.12**	112.92 ± 22.92	84.73 ± 18.24**
BMI (kg/m²)	39.75 ± 6.32	28.63 ± 4.23**	39.62 ± 6.22	29.53 ± 4.44**	39.66 ± 6.23	29.24 ± 4.35**
NC (cm)	42.42 ± 4.27	37.44 ± 3.73**	43.38 ± 4.80	38.61 ± 4.26**	43.07 ± 4.64	38.23 ± 4.10**
WC (cm)	122.06 ± 15.19	94.97 ± 12.34**	119.93 ± 14.55	97.18 ± 11.98**	120.59 ± 14.73	96.47 ± 12.03**
HC (cm)	122.43 ± 11.41	101.55 ± 9.51**	121.61 ± 11.84	105.21 ± 9.41**	121.87 ± 11.66	104.03 ± 9.51**
WHR	1.00 ± 0.06	0.93 ± 0.05**	0.98 ± 0.08	0.92 ± 0.06**	0.99 ± 0.07	0.92 ± 0.06**
SBP (mmHg)	132.65 ± 14.44	112.23 ± 11.78**	135.02 ± 15.93	123.67 ± 12.23**	134.27 ± 15.45	120.07 ± 13.12**
DBP (mmHg)	84.02 ± 9.90	68.00 ± 12.20**	84.63 ± 10.83	78.81 ± 8.88**	84.44 ± 10.51	75.40 ± 11.14**
sUA (umol/L)	324.63 ± 44.09	317.77 ± 65.24	467.26 ± 82.02b	410.48 ± 93.32b**	422.69 ± 98.03	381.21 ± 95.35**
Glucose metabolism
FPG(mmol/L)	5.95 ± 1.33	4.65 ± 0.86**	5.98 ± 1.80	4.77 ± 0.73**	5.97 ± 1.67	4.73 ± 0.77**
FINS (mIU/L)	32.08 ± 22.17	8.33 ± 3.62**	34.39 ± 22.21	11.88 ± 5.93b**	33.67 ± 22.13	10.71 ± 5.52**
FCP (mmol/L)	4.22 ± 1.97	2.27 ± 0.62**	4.71 ± 1.60	2.56 ± 0.80**	4.55 ± 1.73	2.46 ± 0.75**
HOMA-IR	9.25 ± 6.78	1.68 ± 0.69**	9.13 ± 6.50	2.61 ± 1.62b**	9.17 ± 6.56	2.30 ± 1.44**
LNIR	0.86 ± 0.30	0.18 ± 0.19**	0.87 ± 0.26	0.33 ± 0.28a**	0.87 ± 0.27	0.28 ± 0.26**
FGIR	4.75 ± 2.84	12.54 ± 7.76**	4.44 ± 4.48	9.76 ± 7.26**	4.52 ± 4.07	10.67 ± 7.48**
HBA1c(%)	6.33 ± 1.29	5.35 ± 0.62**	6.23 ± 1.20	5.26 ± 0.52**	6.26 ± 1.22	5.29 ± 0.55**
Lipid metabolism
TG (mmol/L)	1.75 ± 1.54	0.81 ± 0.31	2.14 ± 2.36	0.99 ± 0.49**	2.02 ± 2.14	0.93 ± 0.44**
TC (mmol/L)	4.34 ± 1.01	4.24 ± 0.99	4.68 ± 0.99	4.52 ± 0.91	4.57 ± 1.01	4.43 ± 0.94
LDL (mmol/L)	2.61 ± 0.77	2.61 ± 0.98	2.93 ± 0.87	2.87 ± 0.75	2.83 ± 0.85	2.79 ± 0.83
HDL (mmol/L)	1.03 ± 0.28	1.17 ± 0.18**	1.00 ± 0.19	1.20 ± 0.24b**	1.01 ± 0.22	1.19 ± 0.22**

Data presented as mean ± SD; Compare HUA group to NUA group at baseline, ^a P < 0.05, ^b P < 0.01; Compare group after 6 months to baseline *P < 0.05, **P < 0.01

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com